Hikma Pharmaceuticals's total assets for Q4 2024 were $5.13B, an increase of 5.90% from the previous quarter. GB:HIK total liabilities were $2.81B for the fiscal quarter, a 10.40% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.